People
The EUSA Pharma Board of Directors

Ian Lobley
Non-executive Director

Ian Lobley is Lead Partner in 3i's Venture Portfolio team which is responsible for managing investments in the Technology and Healthcare sectors around the world. He has been with 3i since 1987, investing in businesses seeking to exploit technology and market advantage to achieve exponential growth. Whilst active across Europe and USA, Ian is currently based in London, UK, and has also been based in Paris, France.

Ian specialises in information technology and semiconductor investments. Key deals he has been involved in include Bookham, a leading supplier of optical components; Sophos, a world leader in protecting businesses against viruses and malware; Searchspace, a leading provider of financial risk management software; Magic4 and Paragon Software, both mobile device software companies separately acquired by Openwave; Merlin Communications, a spinout of the BBC World Service transmission business, Dibcom world leader in mobile TV chipsets and The Cloud, Europe's leading WiFi provider. In the healthcare field Ian invested in Oxagen and OGS and led the sale of SpineNext to Abbott.

Currently Ian is a director of a number of other exciting companies including ; Nujira providing dramatic improvements to the efficiency of cellular and broadcast systems; Sulake provider of the on-line phenomenon Habbo Hotel and Ipanema, provider of world leading network application management software.

Ian has served on various advisory boards including the European Objective One Programme, Silicon Valley Bank Europe, the European Technology Forum and the Oxford BiotechNet. Ian has a degree in Chemical Engineering.